Brighton Jones’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Brighton Jones's DGX Position: Q3 2026 in Review
Brighton Jones increased its Quest Diagnostics (DGX) stake by 102% in Q3 2026, buying an estimated $507K and bringing the position to 4,353 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #518.
Brighton Jones first reported a position in DGX in Q2 2017 and has held it in 21 quarters since. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Brighton Jones held 4,353 shares of Quest Diagnostics worth $1.01M as of Q3 2026.
- Brighton Jones bought 2,193 Quest Diagnostics shares in Q3 2026, an estimated $507K.
- Quest Diagnostics made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #518 holding.
- Brighton Jones first reported a position in Quest Diagnostics in Q2 2017 and has held it in 21 quarters since.
- 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.